Govt Job for M.Pharm, M.Sc as Junior Research Fellow at ICGEB

The ICGEB is an international, nonprofit research organization. Established as a special project of UNIDO, it became fully autonomous in 1994 and now counts over 60 Member States.

The International Centre for Genetic Engineering and Biotechnology provides a scientific and educational environment of the highest standard and conducts innovative research in life sciences for the benefit of developing countries.

One Junior Research Fellow (JRF) position is available in the Membrane Protein Biology Group, ICGEB, New Delhi component.

Post : Junior Research Fellow (JRF) Position in Atherosclerosis

Fellowship and Duration : Rs. 25000/- per month (consolidated). The project is funded for 1 year only.

Educational Qualifications : BSc with diploma laboratory technician (histopathology) and experience or M.Pharm / MSc. Applicants with prior experience in animal handling and /or histopathology are desirable.

Job description : The applicant will primarily work with ApoE-/- and ApoE-/- Fbn1C1039G+/− mice models of atherosclerosis; design of experiments, drug screening, collection of blood for assays and perform histopathology, data recording and analysis.

How to apply : Interested candidates should mail their application with a cover letter to: samslab.icgeb@gmail.com as a single PDF or word file.

Those who want to post their application should send their CV (less than 3 pages) and a cover letter (one page) to :

Membrane Protein Biology Group, ICGEB
Aruna Asaf Ali Marg, New Delhi-110067.

Last Date to Apply : 30 JULY 2021(or until filled)
Tentative Online Interview date: 5 JULY 2021
Short-listed candidates will be intimated by e-mail.
Queries can be addressed to: samslab.icgeb@gmail.com

Related Posts

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

The Maharashtra Food and Drug Administration (FDA) seized 3,098.46 tonnes of food stock worth Rs 63.45 crore and suspended 954 food licences during a statewide enforcement drive in the past…

Stents to syringes: Serious harm reports surge, but makers remain unnamed

6-year data disclosed first time by Indian Pharmacopoeia Commission on CIC order The Indian Pharmacopoeia Commission (IPC) has, for the first time, disclosed the number of Serious Adverse Events (SAEs)…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

Stents to syringes: Serious harm reports surge, but makers remain unnamed

Stents to syringes: Serious harm reports surge, but makers remain unnamed

NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Medicines that cure Us are making Our Environment Sick

Medicines that cure Us are making Our Environment Sick